Summary

Bioheart, Inc. (Bioheart) is a biotechnology company. It focuses solely on providing cell technologies that aid in the treatment of cardiovascular and related diseases. Its product candidates include Myocell, Myocell SDF-1, Myocath, and Adipocell. Myocell is a muscle stem cell theraphy that intends to improve the cardiac function of a damaged heart after a severe heart attack Myocell SDF-1 is an improved version of Myocell. Here the myoblast cells to be injected are gene-modified prior to injection by an adenovirus vector so that they will release extra quantities of stromal derived factor – 1 or SDF-1 protein. Myocath is a disposable needle injection catheter that is used to deliver biologic solutions to a targeted treatment sitewithin the inner wall of the heart. Adipocell is to treat patients with chronic ischemic cardiomyopathy, The company has recently applied to the FDA to begin trials with Adipocell. The company is currently conducting clinical trials for all of its product candidates in Europe and the US. Bioheart is headquartered in Florida, the US.

Bioheart, Inc. (BHRT) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Bioheart, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 5
Bioheart, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 6
Bioheart, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 7
Bioheart, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 8
Bioheart, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 9
Bioheart, Inc., Medical Equipment, Deal Details 10
Partnerships 10
Bioheart Extends Licensing Agreement With Airspeed Equity 10
Bioheart Enters Into Licensing Agreement With Airspeed Equity 11
Bioheart Signs Licensing Agreement With Monebo 12
Bioheart Enters Into Licensing Agreement With Ageless Regenerative Institute For Adipose Cell Technology 13
Equity Offering 14
Bioheart Completes Private Placement Of Shares For US$3 Million 14
Bioheart Completes Private Placement Of Shares 15
Bioheart Announces Private Placement Of Shares For US$2 Million 16
Bioheart Receives Equity Investment From AnC Bio Holdings 17
Bioheart Completes Private Placement Of US$2.9 Million 18
Bioheart Announces Private Placement Of US$7 Million 19
BioHeart Completes Private Placement Of US$1.8 Million 20
BioHeart Completes IPO Of US$5.78 Million 21
Bioheart, Inc. - Key Competitors 23
Key Employees 24
Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Strategy And Business Planning 26
Nov 25, 2013: Bioheart Announces New Clinical Site in Mexico 26
Nov 04, 2013: Bioheart Announces Agreement With Global Stem Cell Group to Provide Bioheart Therapies and Training 26
Financial Announcements 26
May 09, 2013: Bioheart Reports Q1 2013 Results 26
Mar 29, 2013: Bioheart Reports 2012 Results 27
Corporate Communications 28
Dec 19, 2013: Bioheart Reports Update on CEO 28
Nov 18, 2013: Bioheart's President/CEO Mike Tomas Named Chair of the eMerge Innovate Advisory Board of eMerge Americas 28
Sep 23, 2013: Bioheart Boosts Team with Regulatory, Finance and Administrative Expertise Three New Key Positions Added 29
Aug 28, 2013: Sheldon T. Anderson Elected to the Board of Directors of Bioheart, Inc. 29
Government and Public Interest 30
Dec 31, 2013: Bioheart to Present at Vail Symposium's Winter Program on Cell Therapy 30
Product News 30
Jul 02, 2013: Bioheart Announces Phase III MIRROR Trial for MyoCell Initiated 30
Clinical Trials 30
Jul 02, 2013: Bioheart Announces Phase III MIRROR Trial for MyoCell Initiated 30
Other Significant Developments 31
Feb 24, 2014: Bioheart Reports Positive Update on CEO Mike Tomas 31
Dec 02, 2013: Bioheart Announces Agreement With StemMD to Provide Bioheart Therapies to Its Network 31
Oct 25, 2013: Bioheart Announces Agreement With Anosis to Distribute Products in the Middle East 31
Oct 16, 2013: Bioheart Announces Contract With African-Middle East Medical to Begin Distributing Stem Cell Products in Uganda 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables

Bioheart, Inc., Medical Equipment, Key Facts, 2013 1
Bioheart, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 1
Bioheart, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 1
Bioheart, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 1
Bioheart, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 1
Bioheart, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 5
Bioheart, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 6
Bioheart, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 7
Bioheart, Inc., Deals By Market, 2008 to YTD 2014 8
Bioheart, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 9
Bioheart Extends Licensing Agreement With Airspeed Equity 10
Bioheart Enters Into Licensing Agreement With Airspeed Equity 11
Bioheart Signs Licensing Agreement With Monebo 12
Bioheart Enters Into Licensing Agreement With Ageless Regenerative Institute For Adipose Cell Technology 13
Bioheart Completes Private Placement Of Shares For US$3 Million 14
Bioheart Completes Private Placement Of Shares 15
Bioheart Announces Private Placement Of Shares For US$2 Million 16
Bioheart Receives Equity Investment From AnC Bio Holdings 17
Bioheart Completes Private Placement Of US$2.9 Million 18
Bioheart Announces Private Placement Of US$7 Million 19
BioHeart Completes Private Placement Of US$1.8 Million 20
BioHeart Completes IPO Of US$5.78 Million 21
Bioheart, Inc., Key Competitors 23
Bioheart, Inc., Key Employees 24

List of Figures

Bioheart, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 1
Bioheart, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 5
Bioheart, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 6
Bioheart, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 7
Bioheart, Inc., Medical Equipment, Deals by Market, 2008 to YTD 2014 8

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

Bone Regeneration - Pipeline Review, H2 2014

Bone Regeneration - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • September 2014
  • by Global Markets Direct

Bone Regeneration - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Bone Regeneration - Pipeline Review, H2 2014', provides an overview of the Bone Regeneration's therapeutic pipeline. This ...

BioHeart, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

BioHeart, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.